Liam Ratcliffe Insider Trading
Get free email notifications about insider trading for Liam Ratcliffe.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Liam Ratcliffe. Liam Ratcliffe is a Director in ARRAY BIOPHARMA INC ($ARRY) and a Director in Edge Therapeutics, Inc. ($EDGE) and a Director in Unum Therapeutics Inc. ($UMRX) and a Director in Deciphera Pharmaceuticals, Inc. ($DCPH) and a Director in ARVINAS INC. ($ARVN) and a Director in Aptinyx Inc. ($APTX).
Address: C/O NEW LEAF VENTURE PARTNERS 7 TIMES SQUARE, SUITE 3502 NEW YORK 10036 NY
Companies in which Liam Ratcliffe is an Insider
Aptinyx Inc.
Trading Symbol: APTXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Liam Ratcliffe: Director
Holdings: 1,047,450 shares
Latest Transaction: Apr 02 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ARRAY BIOPHARMA INC
Trading Symbol: ARRYIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Liam Ratcliffe: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Oct 25 2013
$ARRY Market Capitalization: $1.80B
$ARRY Previous Close: $10.53
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ARVINAS, INC.
Trading Symbol: ARVNIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Liam Ratcliffe: Director
Holdings: 822,857 shares
Latest Transaction: Dec 21 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Cogent Biosciences, Inc.
Trading Symbol: COGTIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Liam Ratcliffe: Director
Holdings: 622,772 shares
Latest Transaction: Jun 18 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Deciphera Pharmaceuticals, Inc.
Trading Symbol: DCPHIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Liam Ratcliffe: Director
Holdings: 839,110 shares
Latest Transaction: May 21 2018
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
PDS Biotechnology Corp
Trading Symbol: EDGEIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Liam Ratcliffe: Director
Holdings: 10,000 shares
Current Value: $95,500
Latest Transaction: Mar 18 2019
$EDGE Market Capitalization: $272.98M
$EDGE Previous Close: $9.55
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Liam Ratcliffe
Sentiment: All, APTX, ARRY, ARVN, COGT, DCPH, EDGE
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 21 2020 | ARVN | ARVINAS, INC. | Ratcliffe Liam | Director | Buy | P | 70.00 | 142,857 | 9,999,990 | 822,857 | 680 K to 822.9 K (+21.01 %) |
Jun 04 2020 | ARVN | ARVINAS, INC. | Ratcliffe Liam | Director | Option Exercise | A | 33.57 | 12,000 | 402,840 | 12,000 | |
May 27 2020 | ARVN | ARVINAS, INC. | Ratcliffe Liam | Director | Option Exercise | M | 22.06 | 6,500 | 143,390 | 6,423 | |
May 27 2020 | ARVN | ARVINAS, INC. | Ratcliffe Liam | Director | Buy | M | 22.06 | 6,500 | 143,390 | 6,500 | 0 to 6.5 K |
Nov 14 2019 | ARVN | ARVINAS, INC. | Ratcliffe Liam | Director | Buy | P | 22.00 | 680,000 | 14,960,000 | 680,000 | 0 to 680 K |
Jun 18 2019 | UMRX | Unum Therapeutics ... | Ratcliffe Liam | Director | Option Exercise | A | 2.43 | 7,881 | 19,151 | 7,881 | |
May 28 2019 | ARVN | ARVINAS, INC. | Ratcliffe Liam | Director | Option Exercise | A | 22.06 | 12,923 | 285,081 | 12,923 |